Efficacy and Safety of Adjunctive Cilostazol to Clopidogrel‐Treated Diabetic Patients With Symptomatic Lower Extremity Artery Disease in the Prevention of Ischemic Vascular Events

BACKGROUND: Type 2 diabetes mellitus is a risk factor for lower extremity arterial disease. Cilostazol expresses antiplatelet, anti‐inflammatory, and vasodilator actions and improves the claudication intermittent symptoms. We investigated the efficacy and safety of adjunctive cilostazol to clopidogr...

Descripción completa

Detalles Bibliográficos
Autores principales: Kalantzi, Kallirroi, Tentolouris, Nikolaos, Melidonis, Andreas J., Papadaki, Styliani, Peroulis, Michail, Amantos, Konstantinos A., Andreopoulos, George, Bellos, George I., Boutel, Dimitrios, Bristianou, Magdalini, Chrisis, Dimitrios, Dimitsikoglou, Nikolaos A., Doupis, John, Georgopoulou, Chrysoula, Gkintikas, Stergios A., Iraklianou, Styliani, Kanellas, Κonstantinos, Kotsa, Kalliopi, Koufakis, Theocharis, Kouroglou, Maria, Koutsovasilis, Anastasios G., Lanaras, Leonidas, Liouri, Eirini, Lixouriotis, Charalampos, Lykoudi, Akrivi, Mandalaki, Efthymia, Papageorgiou, Evanthia, Papanas, Nikolaos, Rigas, Spyridon, Stamatelatou, Maria I., Triantafyllidis, Ioannis, Trikkalinou, Aikaterini, Tsouka, Aikaterini N., Zacharopoulou, Ourania, Zoupas, Christos, Tsolakis, Ioannis, Tselepis, Alexandros D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7955466/
https://www.ncbi.nlm.nih.gov/pubmed/33327737
http://dx.doi.org/10.1161/JAHA.120.018184

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7955466/
https://www.ncbi.nlm.nih.gov/pubmed/33327737
http://dx.doi.org/10.1161/JAHA.120.018184

Ejemplares similares